Treatment of chronic hepatitis B with lamivudine in renal allograft recipients

被引：12

作者：

Lewandowska, D

Durlik, M

Kukula, K

Cieciura, T

Ciecierski, R

Walewska-Zielecka, B

Szmidt, J

Rowinski, W

Lao, M

机构：

[1] Med Univ Warsaw, Inst Transplantat, PL-02006 Warsaw, Poland

[2] Natl Inst Hyg, Dept Immunopathol, PL-00791 Warsaw, Poland

[3] Med Univ Warsaw, Dept Vasc Surg & Transplantol, Warsaw, Poland

来源：

TRANSPLANTATION PROCEEDINGS | 2000年 / 32卷 / 06期

关键词：

D O I：

10.1016/S0041-1345(00)01260-4

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1369 / 1370

页数：2

共 11 条

[1] Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation [J].

BenAri, Z ;

Shmueli, D ;

Mor, E ;

Shapira, Z ;

TurKaspa, R .

TRANSPLANTATION, 1997, 63 (03) :393-396

[2]

CHINGLUNG L, 1997, J HEPATOL, V25, P241

[3]

DIENSTAG JL, 1995, NEW ENGL J MED, V333, P1656

[4]

DURLIK M, 1998, TRANSPL INT, V11, P135

[5]

Heijtink RA, 1997, J MED VIROL, V53, P282, DOI 10.1002/(SICI)1096-9071(199711)53:3<282::AID-JMV18>3.3.CO

[6]

2-S

[7]

MAGOTTPROCELEWS.M, 1997, HEP POL, V4, P215

[8] MECHANISMS OF ACTION OF INTERFERONS [J].

PETERS, M .

SEMINARS IN LIVER DISEASE, 1989, 9 (04) :235-239

[9] COINFECTION BY HEPATITIS-B VIRUS AND HEPATITIS-C VIRUS IN RENAL-TRANSPLANTATION - MORBIDITY AND MORTALITY IN 1098 PATIENTS [J].

POUTEILNOBLE, C ;

TARDY, JC ;

CHOSSEGROS, P ;

MION, F ;

CHEVALLIER, M ;

GERARD, F ;

CHEVALLIER, P ;

MEGAS, F ;

LEFRANCOIS, N ;

TOURAINE, JL .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 :122-124

[10] Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation [J].

Rostaing, L ;

Henry, S ;

Cisterne, JM ;

Duffaut, M ;

Icart, J ;

Durand, D .

TRANSPLANTATION, 1997, 64 (11) :1624-1627

← 1 2 →